Edward R. Truitt

Ed is a life sciences entrepreneur, investor and board member. He is CEO of Lubris BioPharma, which is developing a therapeutic protein for dry eye and inflammation-related conditions. Lubris sold its ophthalmology portfolio to Novartis. Mr. Truitt is co-founder of Biological Dynamics, a developer of oncology diagnostics and he serves on the Board of Sound Life Sciences. Previously, Mr. Truitt practiced corporate law, focusing on business formation and technology licensing. Mr. Truitt received his JD from University of San Diego and BA from UC Santa Barbara.